Literature DB >> 23733121

Central nervous system changes in glaucoma.

Yeni Yücel1.   

Abstract

Many glaucoma patients continue to lose vision despite treatment to lower intraocular pressure. In addition to the loss of retinal ganglion cells in the eye, there is injury to major visual pathways of the brain along the retino-geniculo-cortical pathway. Evidence for this comes from both glaucoma models and glaucoma patients. Understanding central visual system changes in glaucoma will provide insights into human glaucomatous neural degeneration and disease progression, in addition to potential novel strategies to prevent vision loss in glaucoma.

Entities:  

Mesh:

Year:  2013        PMID: 23733121     DOI: 10.1097/IJG.0b013e3182934a55

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  9 in total

Review 1.  Exciting directions in glaucoma.

Authors:  Carol A Rasmussen; Paul L Kaufman
Journal:  Can J Ophthalmol       Date:  2014-12       Impact factor: 1.882

Review 2.  Heat shock proteins in the retina: Focus on HSP70 and alpha crystallins in ganglion cell survival.

Authors:  Natik Piri; Jacky M K Kwong; Lei Gu; Joseph Caprioli
Journal:  Prog Retin Eye Res       Date:  2016-03-24       Impact factor: 21.198

3.  Monitoring the haemodynamic response to visual stimulation in glaucoma patients.

Authors:  R Re; D Messenio; G Marano; L Spinelli; I Pirovano; D Contini; R Colombo; P Boracchi; E Biganzoli; R Cubeddu; A Torricelli
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

4.  Intraocular pressure reduction and neuroprotection conferred by bone marrow-derived mesenchymal stem cells in an animal model of glaucoma.

Authors:  Christophe Roubeix; David Godefroy; Céline Mias; Anaïs Sapienza; Luisa Riancho; Julie Degardin; Valérie Fradot; Ivana Ivkovic; Serge Picaud; Florian Sennlaub; Alexandre Denoyer; William Rostene; José Alain Sahel; Stéphane Melik Parsadaniantz; Françoise Brignole-Baudouin; Christophe Baudouin
Journal:  Stem Cell Res Ther       Date:  2015-09-16       Impact factor: 6.832

Review 5.  Residual vision activation and the brain-eye-vascular triad: Dysregulation, plasticity and restoration in low vision and blindness - a review.

Authors:  Bernhard A Sabel; Josef Flammer; Lotfi B Merabet
Journal:  Restor Neurol Neurosci       Date:  2018       Impact factor: 2.406

Review 6.  Potential therapeutic applications of mesenchymal stem cells for the treatment of eye diseases.

Authors:  Giuliana Mannino; Cristina Russo; Anna Longo; Carmelina Daniela Anfuso; Gabriella Lupo; Debora Lo Furno; Rosario Giuffrida; Giovanni Giurdanella
Journal:  World J Stem Cells       Date:  2021-06-26       Impact factor: 5.326

Review 7.  Glaucoma: the retina and beyond.

Authors:  Benjamin Michael Davis; Laura Crawley; Milena Pahlitzsch; Fatimah Javaid; Maria Francesca Cordeiro
Journal:  Acta Neuropathol       Date:  2016-08-20       Impact factor: 17.088

8.  Analyzing the impact of glaucoma on the macular architecture using spectral-domain optical coherence tomography.

Authors:  Jan D Unterlauft; Matus Rehak; Michael R R Böhm; Franziska G Rauscher
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

9.  Association between Daily Niacin Intake and Glaucoma: National Health and Nutrition Examination Survey.

Authors:  Teerajet Taechameekietichai; Sunee Chansangpetch; Pimnara Peerawaranun; Shan C Lin
Journal:  Nutrients       Date:  2021-11-26       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.